September 27, 2017 |
Diabetes Medications Not Decreased in Medicare Patients With Low Blood Sugar In a study focusing on 10 states, more than 10% of Medicare beneficiaries with diabetes had very low blood sugar, yet more than 85% of that group continued on the same or higher dosages of glucose-lowering medications. Find out why study authors consider this a critical problem. |
Hormone Therapy Doesn’t Increase Mortality in Postmenopausal Women Use of hormone therapy in postmenopausal women plummeted because of concerns about dangerous side effects. Yet a new study finds that women using either an estrogen-progestin combination or estrogen alone do not have higher mortality rates in general or from specific causes such as cardiovascular disease and cancer. Here are the details. |
Levofloxacin Appears to Be Best Prophylactic for Pediatric ALL Patients Chemotherapy treatment-related infections can be killers for children with acute lymphoblastic leukemia. A new study identifies the best antibiotics to use prophylactically to avoid those infections, including deadly Clostridium difficile. Here is what researchers recommend. |
Twice-Daily Aspirin Might Better Protect Diabetes Patients From CVD A once-daily aspirin might not be good enough to protect type 2 diabetes patients against cardiovascular disease (CVD). That is according to a new study which suggests that twice-daily dosing might be more effective. Here is why the researchers came to that conclusion. |